(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) released new death estimates for seasonal flu today that are designed to move away from a single number and instead take into account the disease's unpredictability and the extra toll inflicted when influenza A H3N2 is the dominant strain.
Sept 23, 2009 (CIDRAP News) To mask or not to mask, hand washing versus hand sanitizers, how long to stay away from the workplace if sick with novel H1N1 influenza, tips for travelthese were some of the issues addressed in a panel discussion yesterday during a business preparedness summit in Minneapolis.
(CIDRAP News) A newly published analysis of oseltamivir-resistant influenza viruses collected last winter in Norway hints that they may increase an infected person's risk of pneumonia and sinus infections, but the small number of patients in the study means the finding is no more than a hint at this point.
(CIDRAP News) The distribution of more than $5 billion in federal funds since 2001 has greatly improved states' preparedness to deal with disease outbreaks, natural disasters, and other public health emergencies, the Centers for Disease Control and Prevention (CDC) said today in a first-of-its-kind assessment.
Editor's Note: CIDRAP's Promising Practices: Pandemic Influenza Preparedness Tools online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a biweekly series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.